The results from our study suggest, for the first time, that the TGFβ1 rs1982073 variant genotypes may be useful as a genetic biomarker to help physicians tailor the treatment according to the patient’s risk of radiation pneumonitis and DM. The gene discussed is TGFB1; the disease is radiation pneumonitis.